0001567619-20-004493.txt : 20200220 0001567619-20-004493.hdr.sgml : 20200220 20200220172729 ACCESSION NUMBER: 0001567619-20-004493 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200218 FILED AS OF DATE: 20200220 DATE AS OF CHANGE: 20200220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SZOSTAK M ANNE CENTRAL INDEX KEY: 0001094176 STANDARD INDUSTRIAL CLASSIFICATION: MANIFOLD BUSINESS FORMS [2761] STATE OF INCORPORATION: DE FISCAL YEAR END: 0627 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 20636469 MAIL ADDRESS: STREET 1: C/O TUPPERWARE BRANDS CORP STREET 2: 14901 S ORANGE BLOSSOM TR CITY: ORLANDO STATE: FL ZIP: 32837 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2020-02-18 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001094176 SZOSTAK M ANNE ONE IDEXX DRIVE WESTBROOK ME 04092 1 0 0 0 Common Stock 2020-02-18 4 M 0 8790 43.68 A 9734 D Common Stock 2020-02-18 4 G 0 8790 0 D 584 D Common Stock 2020-02-18 4 G 0 8790 0 A 11796 I M. Anne Szostak Trust Common Stock 2020-02-18 4 S 0 7590 286.1780 D 4116 I M. Anne Szostak Trust Common Stock 2020-02-18 4 S 0 1200 286.9820 D 2916 I M. Anne Szostak Trust Common Stock 6717 I 2018 Szostak IDEXX GRAT Non-Qualified Stock Option (right-to-buy) 43.68 2020-02-18 4 M 0 8790 D 2023-05-07 Common Stock 8790 0 D Represents the weighted average price of the shares sold ranging from a low of $285.76 to a high of $286.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $286.77 to a high of $287.49 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Grant of option to buy 4,395 shares of IDEXX Laboratories, Inc. common stock that became exercisable in one annual installment on May 8, 2014 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for M. Anne Szostak 2020-02-20